Nayak Abhay U Reports Phantom Stock Transaction at Zoetis
Nayak Abhay U, Executive VP at Zoetis, reports a phantom stock transaction, highlighting trends in executive compensation within the pharmaceutical sector.
Semler Dakota sells shares to cover tax obligations
Semler Dakota, CEO of Xos, Inc., reports share sale for tax obligations, reflecting executive management strategies in the motor vehicle parts industry.
Aziz Kabeer Discloses Stock Transaction in AN2 Therapeutics
Aziz Kabeer reports a transaction of 2,465 shares in AN2 Therapeutics, reflecting his ongoing involvement and significant ownership in the company.
Sordoni Giordano Reports Stock Transaction at Xos, Inc.
Sordoni Giordano, COO of Xos, Inc., reports a significant stock transaction involving over 13,000 shares, reflecting ongoing equity management.
Donini Oreola Cancels Stock Options in SEC Filing
Donini Oreola has voluntarily surrendered stock options for cancellation, impacting ownership status and reflecting trends in the pharmaceutical industry.
Soligenix CEO Schaber Cancels Stock Options in Strategic Move
Soligenix, Inc. CEO Christopher J. Schaber voluntarily cancels stock options, signaling a strategic shift in the company's approach to executive compensation.
CFO Guarino Surrenders Stock Options at Soligenix, Inc.
CFO Jonathan L. Guarino of Soligenix, Inc. voluntarily surrenders stock options for cancellation, reflecting strategic decisions in the pharmaceutical sector.
Atlas Energy Solutions' Voelter Acquires 27,086 Shares
Dathan C. Voelter, General Counsel and Secretary of Atlas Energy Solutions, acquires 27,086 shares, reflecting confidence in the company's future.
Saba Capital Management Disposes of Shares in PIMCO Fund
Saba Capital Management reports a significant share disposal in PIMCO Dynamic Income Strategy Fund, reflecting ongoing market adjustments.
Glicklich Alan acquires 20,000 stock options at CalciMedica
Alan Glicklich has acquired 20,000 stock options at CalciMedica, Inc., reflecting trends in executive compensation in the pharmaceutical sector.
Goodson Alan R reports share sale in abrdn Healthcare Investors
Alan R. Goodson has reported a share sale in abrdn Healthcare Investors, signaling potential shifts in ownership within the healthcare investment sector.
Saba Capital Management increases stake in Mexico Fund Inc.
Saba Capital Management boosts its holdings in Mexico Fund Inc., now owning over 2.39 million shares, signaling a strategic investment move.
Saba Capital Management boosts stake in New Germany Fund Inc.
Saba Capital Management increases its ownership in New Germany Fund Inc. to over 3.7 million shares, signaling confidence in the fund's future.
eBay CEO Jamie Iannone Sells Shares Amid Ongoing Transactions
eBay CEO Jamie Iannone sold shares in recent transactions, reflecting ongoing management activity in the tech sector. This may impact investor perceptions.
Public Storage's Havner Reports Share Transaction in SEC Filing
Ronald L. Havner Jr. of Public Storage reported a share transaction, reflecting confidence in the company's future and the real estate investment trust industry.
Lapointe Surrenders Stock Options in Soligenix, Inc. Move
Gregg A. Lapointe voluntarily surrenders stock options, impacting his ownership in Soligenix, Inc. This decision may influence industry trends in executive compensation.
Khator Renu Reports Phantom Stock Unit Transactions
Khator Renu's SEC filing reveals transactions involving phantom stock units and deferred stock units related to PNC Financial Services Group.
Public Storage's Ronald P. Spogli Reports Share Transaction
Ronald P. Spogli of Public Storage reported a share transaction, indicating ongoing equity compensation strategy amid industry trends.
Sunarto Haryanto Lee acquires shares in Provident Financial
Sunarto Haryanto Lee, Vice President of Provident Financial Holdings, acquires shares, signaling confidence in the company's future.
Gunn Justin Frederick acquires 100,000 stock options
Gunn Justin Frederick reports acquisition of 100,000 stock options at Corcept Therapeutics, reflecting executive commitment in the pharmaceutical sector.